Chemed Corporation announces $300 million stock repurchase authorization and a quarterly dividend of 60-cents per share.
Quiver AI Summary
Chemed Corporation announced the authorization of an additional $300 million for stock repurchases as part of its ongoing share repurchase program, which will be financed through operational cash and a revolving credit facility. The company's Board of Directors also declared a quarterly cash dividend of 60 cents per share, payable on March 13, 2026, to shareholders on record by February 23, 2026. This dividend matches the amount paid in December 2025 and marks the 219th consecutive quarterly dividend since Chemed became a public company 54 years ago. Chemed, headquartered in Cincinnati, operates VITAS Healthcare, a leading provider of hospice care, and Roto-Rooter, a prominent plumbing and drain cleaning service. The press release also includes caution about forward-looking statements concerning the company's future performance, highlighting the inherent risks associated with such predictions.
Potential Positives
- Chemed Corporation has authorized an additional $300 million for stock repurchase, indicating confidence in the company's financial health and a commitment to returning value to shareholders.
- The declaration of a quarterly cash dividend of 60-cents per share reinforces the company's strong track record of consistent returns, marking the 219th consecutive quarterly dividend payment.
- The dividend is payable to shareholders of record as of February 23, 2026, demonstrating ongoing financial stability and commitment to shareholder rewards.
Potential Negatives
- The announcement of the stock repurchase program indicates a potential lack of investment opportunities for growth, as the company is opting to buy back shares instead of reinvesting in its operations or expanding its services.
- Utilizing its revolving credit facility to fund the stock repurchases may raise concerns regarding the company's debt levels and financial stability.
- The equal dividend amount compared to the previous quarter may suggest stagnation in the company's profitability and inability to increase returns to shareholders, despite a long history of consistent dividends.
FAQ
What is the amount authorized for Chemed's stock repurchase program?
Chemed's Board of Directors has authorized an additional $300 million for its stock repurchase program.
When will the quarterly cash dividend be paid?
The quarterly cash dividend will be payable on March 13, 2026.
How much is Chemed's quarterly cash dividend?
Chemed has declared a quarterly cash dividend of 60 cents per share.
What are Chemed Corporation's primary business segments?
Chemed operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter.
What is the significance of Chemed's dividend announcement?
This marks the 219th consecutive quarterly dividend paid by Chemed in its 54 years as a public company.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$CHE Insider Trading Activity
$CHE insiders have traded $CHE stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $CHE stock by insiders over the last 6 months:
- KEVIN J MCNAMARA (president and CEO) has made 0 purchases and 2 sales selling 5,000 shares for an estimated $2,258,940.
- PATRICK P GRACE sold 150 shares for an estimated $69,508
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CHE Revenue
$CHE had revenues of $624.9M in Q3 2025. This is an increase of 3.09% from the same period in the prior year.
You can track CHE financials on Quiver Quantitative's CHE stock page.
$CHE Hedge Fund Activity
We have seen 229 institutional investors add shares of $CHE stock to their portfolio, and 337 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 5,549,876 shares (+2444879.3%) to their portfolio in Q4 2025, for an estimated $2,374,569,945
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 133,292 shares (-76.7%) from their portfolio in Q4 2025, for an estimated $57,030,315
- VICTORY CAPITAL MANAGEMENT INC added 109,033 shares (+1260.2%) to their portfolio in Q4 2025, for an estimated $46,650,859
- FMR LLC removed 103,005 shares (-54.6%) from their portfolio in Q3 2025, for an estimated $46,119,458
- SCHRODER INVESTMENT MANAGEMENT GROUP removed 86,625 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $38,785,477
- M&T BANK CORP added 85,107 shares (+10291.1%) to their portfolio in Q4 2025, for an estimated $36,413,881
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 84,208 shares (+740.9%) to their portfolio in Q3 2025, for an estimated $37,703,289
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CHE Analyst Ratings
Wall Street analysts have issued reports on $CHE in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 11/10/2025
- B of A Securities issued a "Buy" rating on 09/10/2025
- Jefferies issued a "Buy" rating on 09/02/2025
To track analyst ratings and price targets for $CHE, check out Quiver Quantitative's $CHE forecast page.
$CHE Price Targets
Multiple analysts have issued price targets for $CHE recently. We have seen 3 analysts offer price targets for $CHE in the last 6 months, with a median target of $572.0.
Here are some recent targets:
- Brian Tanquilut from Jefferies set a target price of $475.0 on 01/22/2026
- Ben Hendrix from RBC Capital set a target price of $572.0 on 11/10/2025
- Joanna Gajuk from B of A Securities set a target price of $595.0 on 09/10/2025
Full Release
CINCINNATI, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed’s existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.
The Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company’s capital stock, payable on March 13, 2026, to shareholders of record as of February 23, 2026. This is equal to the dividend paid in December 2025. This represents the 219 th consecutive quarterly dividend paid by Chemed in its 54 years as a public company.
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation ( www.chemed.com ) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.
Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.
CONTACT: Michael D. Witzeman
(513) 762-6714
